COSELA: A PROACTIVE APPROACH TO SIGNIFICANTLY REDUCE THE OCCURRENCE OF SEVERE NEUTROPENIA from pneumonia stage cancer Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: INDICATIONnCOSELA™ (trilaciclib) is indicated to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive-stage small cell lung cancer (ES-SCLC).n nSELLECT IMPORTANT SAFETY INFORMATIONnnCOSELA is contraindicated in patients with a history of serious hypersensitivity reactions to trilaciclib.n nWarnings and precautions include injection-site reactions (includi
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)